These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 14586796)

  • 1. Classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a cross-sectional study of factors involved in bone mineral density.
    de Almeida Freire PO; de Lemos-Marini SH; Maciel-Guerra AT; Morcillo AM; Matias Baptista MT; de Mello MP; Guerra G
    J Bone Miner Metab; 2003; 21(6):396-401. PubMed ID: 14586796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone mineral density and body composition in prepubertal and adolescent patients with the classical form of 21-hydroxylase deficiency.
    Sahakitrungruang T; Wacharasindhu S; Supornsilchai V; Srivuthana S; Kingpetch K
    J Med Assoc Thai; 2008 May; 91(5):705-10. PubMed ID: 18672636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of Bone Mineral Parameters with Anthropometric Measurements and the Effect of Glucocorticoids on Bone Mineral Parameters in Congenital Adrenal Hyperplasia.
    Ganesh R; Suresh N; Janakiraman L; Ravikumar K
    Indian J Pediatr; 2016 Feb; 83(2):126-30. PubMed ID: 26223873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of glucocorticoid replacement therapy on bone mineral density in children with congenital adrenal hyperplasia.
    Cetinkaya S; Kara C
    J Pediatr Endocrinol Metab; 2011; 24(5-6):265-9. PubMed ID: 21823521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Völkl TM; Simm D; Beier C; Dörr HG
    Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone mineral density and bone turnover in Romanian children and young adults with classical 21-hydroxylase deficiency are influenced by glucocorticoid replacement therapy.
    Zimmermann A; Sido PG; Schulze E; Al Khzouz C; Lazea C; Coldea C; Weber MM
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):477-84. PubMed ID: 19170706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone mineral density, bone markers, and fractures in adult males with congenital adrenal hyperplasia.
    Falhammar H; Filipsson Nyström H; Wedell A; Brismar K; Thorén M
    Eur J Endocrinol; 2013 Mar; 168(3):331-41. PubMed ID: 23211577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of an aromatase inhibitor in children with congenital adrenal hyperplasia: Impact of anastrozole on bone mineral density and visceral adipose tissue.
    Halper A; Sanchez B; Hodges JS; Dengel DR; Petryk A; Sarafoglou K
    Clin Endocrinol (Oxf); 2019 Jul; 91(1):124-130. PubMed ID: 31070802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of total cumulative glucocorticoid dose on bone mineral density in patients with 21-hydroxylase deficiency.
    Chakhtoura Z; Bachelot A; Samara-Boustani D; Ruiz JC; Donadille B; Dulon J; Christin-Maître S; Bouvattier C; Raux-Demay MC; Bouchard P; Carel JC; Leger J; Kuttenn F; Polak M; Touraine P;
    Eur J Endocrinol; 2008 Jun; 158(6):879-87. PubMed ID: 18390993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of long-term glucocorticoid therapy on bone mineral density of the patients with congenital adrenal hyperplasia.
    Ünal S; Alikaşifoğlu A; Özön A; Gönç N; Kandemir N
    Turk J Pediatr; 2020; 62(3):359-366. PubMed ID: 32558409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone mineral density in girls with classical congenital adrenal hyperplasia due to CYP21 deficiency.
    Elnecave RH; Kopacek C; Rigatto M; Keller Brenner J; Sisson de Castro JA
    J Pediatr Endocrinol Metab; 2008 Dec; 21(12):1155-62. PubMed ID: 19189689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sexual difference in bone geometry of adult patients with classical congenital adrenal hyperplasia: data using peripheral quantitative computed tomography.
    Bechtold S; Beyerlein A; Bonfig W; Dalla Pozza R; Putzker S; Otto R; Schmidt H; Schwarz HP
    Horm Res Paediatr; 2014; 82(3):171-8. PubMed ID: 25171196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone mineral density and body composition in congenital adrenal hyperplasia.
    Cameron FJ; Kaymakci B; Byrt EA; Ebeling PR; Warne GL; Wark JD
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2238-43. PubMed ID: 7608286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fractures and bone mineral density in adult women with 21-hydroxylase deficiency.
    Falhammar H; Filipsson H; Holmdahl G; Janson PO; Nordenskjöld A; Hagenfeldt K; Thorén M
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4643-9. PubMed ID: 17878254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty.
    Bonfig W; Bechtold S; Schmidt H; Knorr D; Schwarz HP
    J Clin Endocrinol Metab; 2007 May; 92(5):1635-9. PubMed ID: 17299071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth pattern of untreated boys with simple virilizing congenital adrenal hyperplasia indicates relative androgen insensitivity during the first six months of life.
    Bonfig W; Schwarz HP
    Horm Res Paediatr; 2011; 75(4):264-8. PubMed ID: 21196707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of children with classic congenital adrenal hyperplasia: suggestions for age dependent treatment in childhood and puberty.
    Pijnenburg-Kleizen KJ; Thomas CMG; Otten BJ; Roeleveld N; Claahsen-van der Grinten HL
    J Pediatr Endocrinol Metab; 2019 Oct; 32(10):1055-1063. PubMed ID: 31573958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth patterns and final height in congenital adrenal hyperplasia due to classical 21-hydroxylase deficiency. Results of a multicenter study.
    Hargitai G; Sólyom J; Battelino T; Lebl J; Pribilincová Z; Hauspie R; Kovács J; Waldhauser F; Frisch H;
    Horm Res; 2001; 55(4):161-71. PubMed ID: 11598369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Estimation of influence of congenital-adrenal hyperplasia treatment on bone mineralisation evaluated with densitometry].
    Romanowska H; Krzywińska-Zdeb E; Giżewska M; Kotkowiak L; Safranow K; Horodnicka-Józwa A; Petriczko E; Krupa B; Walczak M
    Pediatr Endocrinol Diabetes Metab; 2012; 18(1):21-6. PubMed ID: 22525687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone turnover and bone mineral density in patients with congenital adrenal hyperplasia.
    Guo CY; Weetman AP; Eastell R
    Clin Endocrinol (Oxf); 1996 Nov; 45(5):535-41. PubMed ID: 8977749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.